{
  "docId": "019de075-ab2a-73e5-980a-7d480707ba09",
  "docSlug": "340a1966b9939070959283ec1665bfbf",
  "documentTitle": "Kymera | Investor Presentation Deck | 60 slides",
  "authorId": "kymera",
  "authorName": "Kymera",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 3,
  "pageCount": 60,
  "prevPage": 2,
  "nextPage": 4,
  "slideType": "executive_summary",
  "function": "summarize",
  "density": "dense",
  "nDataPoints": 1,
  "notes": "The slide uses a split-layout with company identity on the left and a list of achievements on the right.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-ab2a-73e5-980a-7d480707ba09/3",
  "deckHref": "/decks/019de075-ab2a-73e5-980a-7d480707ba09",
  "deckJsonHref": "/decks/019de075-ab2a-73e5-980a-7d480707ba09.json",
  "deckAnchorHref": "/decks/019de075-ab2a-73e5-980a-7d480707ba09#slide-3",
  "components": [
    {
      "bbox": {
        "h": 0.6,
        "w": 0.58,
        "x": 0.38,
        "y": 0.0025
      },
      "kind": "list",
      "text": "Advanced four programs to clinical stage; Developed a deep pipeline positioned to deliver ≥1 IND/year; First to advance degrader (KT-474/SAR444656) in healthy volunteers and patients with HS and AD; Demonstrated degrader vs. small molecule inhibitors (SMI) biological and clinical differentiation, and potential best in class profile in I/I; Demonstrated fidelity of translation of PK, PD and safety across three clinical programs in I/I and oncology patients; Unique target selection strategy based on using TPD to unlock high value, undrugged targets; Well-capitalized with $472m of cash, enabling expansion of clinical impact into areas with large clinical and commercial opportunities",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6bbb338a-b39c-4fba-8bd6-b6326246acb3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.3,
        "x": 0.05,
        "y": 0.0038
      },
      "kind": "paragraph",
      "text": "Recognized leader in Targeted Protein Degradation (TPD). Building a fully-integrated, global biotech company. Initial I/I and Oncology focus, but a disease-agnostic platform. Accelerating forward integration through key strategic partnerships.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fd10136d-17a9-49ac-ab71-404bd6ae1c92",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.298,
        "x": 0.51,
        "y": 0.00175
      },
      "kind": "title",
      "text": "Key Accomplishments",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e04e57c7-e3d3-4c75-9063-9e0f1deb939d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.134,
        "x": 0.433,
        "y": 0.04
      },
      "kind": "title",
      "text": "Overview",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f8f1a73c-5dd5-4289-b637-65be9fd64876",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "List presentation",
      "slug": "list-presentation",
      "agent": null,
      "layer": "slide",
      "matchId": "32b2ad30-c8c6-42cd-83fa-fe9aca19606a",
      "evidence": "list/bullet: Advanced four programs to clinical stage; Developed a deep pipeline positioned to deliver ≥1 IND/year; First to advance degrader (KT-474/SAR444656) in healthy volunteers and patients with HS and AD; Demonstr",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 3,
      "from": 1,
      "beatId": "8d2ca796-1fd6-415e-9f3b-ec48709a2039",
      "arcName": "AIDA",
      "arcSlug": "aida",
      "beatName": "Attention",
      "beatSlug": "aida-attention",
      "evidence": "The opening slides grab attention with a clear overview and vision",
      "position": 0,
      "confidence": 0.8,
      "parentBeatName": "Hook",
      "parentBeatSlug": "hook"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}